ANAPHORE, INC.
Patent Owner
Stats
- 2 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 27, 2012 most recent publication
Details
- 2 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 228 Total Citation Count
- Jun 06, 1995 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2012/0135,938 Polypeptides that Bind TRAIL-R1 and TRAIL-R2AbandonedJan 26, 12May 31, 12[A61K, C12N, A61P, C07K]
2012/0094,873 COMBINATORIAL LIBRARIES OF PROTEINS HAVING THE SCAFFOLD STRUCTURE OF C-TYPE LECTIN-LIKE DOMAINSAbandonedJun 08, 11Apr 19, 12[C40B]
2012/0021,995 Polypeptides that Bind TRAIL-R1 and TRAIL-R2AbandonedJul 26, 11Jan 26, 12[A61K, A61P, C07K]
8017559 Combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domainsExpiredDec 04, 06Sep 13, 11[C40B]
2011/0086,770 Combinatorial Libraries Based on C-type Lectin-like DomainAbandonedFeb 10, 10Apr 14, 11[C40B, C07K]
2011/0086,806 Polypeptides that Bind IL-23RAbandonedFeb 10, 10Apr 14, 11[A61K, C07H, C12N, A61P, C40B, C07K]
2011/0027,267 Fusion Proteins of Mannose Binding Lectins for Treatment of DiseaseAbandonedNov 10, 08Feb 03, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0028,403 HSP70-Based Treatment for Autoimmune Diseases and CancerAbandonedMar 12, 10Feb 03, 11[A61K, C07H, C12N, A61P, C07K]
2010/0105,620 Polypeptides that bind Trail-R1 and Trail-R2AbandonedOct 09, 09Apr 29, 10[A61K, C07H, C12N, G01N, C40B, C07K]
2007/0010,658 Trimeric binding proteins for trimeric cytokinesAbandonedOct 29, 03Jan 11, 07[A61K, C07H, C12P, G01N, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.